The percentage of patients with rheumatoid arthritis (RA) chronically using opioids in the USA has risen from 7.4% in 2002 to 16.9% in 2015, according to self-reported usage data from 33,739 patients in the CORRONA registry. Opioid usage was deemed chronic if reported in patient questionnaires at ≥2 consecutive rheumatology clinic visits. Factors associated with an increased risk of incident chronic opioid use in patients with RA included severe pain (HR 2.53, 95% CI 2.19–2.92), antidepressant use (HR 1.79, 95% CI 1.64–1.92), a high degree of disease activity (HR 1.55, 95% CI 1.30–1.84) and a high degree of disability (HR 1.45, 95% CI 1.27–1.65).